A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours

NCT05804526 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumours

Interventions

DRUG: RC88
DRUG: Sintilimab Injection

Sponsor

RemeGen Co., Ltd.